-
Evaluation and Medical Management of Benign
Prostatic Hyperplasia. Beckman and Mynderse. Mayo Clinic
Proceedings. October 2005; 80(10): 1356-1362.
-
The Role of a Lipido-sterolic Extract of
Serenoa repens in the Management of Lower Urinary Tract Symptoms
Associated with Benign Prostatic Hyperplasia. Gerber and
Fitzpatrick. BJU International. April 2004. 94, 338-344
-
Saw Palmetto Extract and Benign Prostatic
Hyperplasia. Gong and Gerber. The American Journal of Chinese
Medicine. 2004. Vol. 32, No. 3, 331-338.
-
Saw Palmetto Extract Suppresses Insulin-Like Growth
Factor-I signaling and Induces Stress-Activated Protein Kinase/c-Jun
N-Terminal Kinase Phosphorylation in Human Prostate Epithelial Cells.
Wadsworth et al. Endocrinology. July 2004, 145 (7): 3205-3214.
-
Saw Palmetto for Prostate Disorders. Gordon and
Shaughnessy. American Family Physician. March 2003; 67 (6).
-
Comparison of Saw Palmetto (extract and whole berry) and
Cernitin on Prostate Growth in Rats. Talpur et al. Molecular and
Cellular Biochemistry. 2003; 250: 21-26.
-
Effects of the Lipido-sterolic Extract of Serenoa
repens (Permixon®) on Infiltrating
Cells and Inflammatory Markers in Prostatic Tissues from BPH
Patients. Vela et al. European Urology. 2002:1 Suppl 1:62.
-
Saw Palmetto Alters Nuclear Measurements Reflecting DNA
Content In Men With Symptomatic BPH: Evidence For A Possible Molecular
Mechanism. Veltri et al. Urology 60: 617-622, 2002.
-
Serenoa repens for Benign Prostatic Hyperplasia (Review).
Wilt T, Ishani A, Mac Donald R. The Cochrane Database of Systematic
Reviews. 2002, Issue 3. Art. No.: CD001423.DOI:
10.1002/14561858.CD001423.
-
Effects of saw Palmetto Herbal Blend in Men with
Symptomatic Benign Prostatic Hyperplasia. Marks et al. Journal of
Urology. 2000 May 163(5): 1451-6
-
Saw Palmetto Extracts Potently and Noncompetitively
Inhibit Human alpha 1-adrenoceptors in vitro. Goepel et al. Prostate.
1999 February 15; 38(3): 208-215
-
Saw Palmetto in Men with Lower Urinary Tract Symptoms:
Effect on Urodynamic Parameters and Voiding Symptoms. Gerber et al. Urology.
1998 June; 51(6): 1003-7.
-
Effect of Permixon®
on Apoptosis and Proliferation in the Prostate of Patients with BPH.
Vacherot et al. Journal of Urology. 1999; 161: 362A.
-
Effect of Lipido-sterolic Extract of Serenoa
repens (Permixon®) and its Major
Components on Basic Fibroblast Growth Factor-induced Proliferation
of Cultures of Human Prostate Biopsies. Paubert-Braquet et al.
European Urology. 1998: 33:340-7.
-
Saw Palmetto. Chavez and Chavez. Hospital
Pharmacy.1998 November; 33/11(1335-1361).
-
Effects of Permixon® on
Phospholipase A2 Activity and on Arachidonic Acid Metabolism in
Cultured Prostatic Cells. Ragab et al. Proceedings of the
International Workshop in Urology 1987 July 22-25. Cannes: Rome:
Acta Medica 1988: 293-6.
-
Harrisons Textbook of Internal Medicine at www.harrisonsonline.com
